Ronjon Chakraverty to lead new Blood and Transplant Research Unit
18 May 2022
The Precision Cellular Therapeutics Unit is one of three new units awarded to the University of Oxford by NIHR.
Funding awarded for autoimmune disease research
13 May 2022
Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
Project funding for personalised childhood cancer treatments
29 April 2022
Funding from the Azaylia Foundation will support the Scientific Advances for Infant Leukaemia (SAIL) programme.
MRC National Mouse Genetics Network Research Clusters Announced
19 April 2022
Centre for Computational Biology MRC MHU RDM
Claus Nerlov and Steve Twigg from the MRC WIMM join the new national network for disease modelling.
RDM announces new Principal Investigators
31 March 2022
Dr Stephen Twigg has been announced as one of eight new Principal Investigators by the Radcliffe Department of Medicine.
Defining the role of resident memory B cells in the fight against influenza
31 March 2022
Researchers at the Kennedy Institute of Rheumatology and the MRC Human Immunology Unit have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
Patient priorities guide Oxford Myeloma research
29 March 2022
Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.
Drive for LEAF Sustainability Accreditation at the MRC WIMM
25 March 2022
Lab sustainability in Oxford was the focus of a seminar for the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) members this Wednesday. The session introduced the Laboratory Efficiency Assessment Framework (LEAF), a nationally recognised scheme to drive reductions in laboratory waste and carbon emissions.
From ‘Ew, gross!’ to ‘Wow!’: Scientists bring immunology to the classroom
25 March 2022
For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day – one of the first of its kind since the start of the pandemic.
New gene target identified to prevent tumour growth under acidity
11 March 2022
New research has identified a new gene that allows cancer cells to survive in the typically acidic microenvironment of a malignant tumour. Researchers have discovered drugs that inhibit the gene in other medical conditions also selectively kill cancer cells at acidic pH, without damaging healthy tissue. This defines a novel strategy for targeting acidic tumour regions.
A Tribute to Dr. Ling Felce
7 March 2022
It is with great sadness that we learnt of the tragic death of Dr Ling Felce, a postdoctoral researcher within Professor Tao Dong's group at the MRC WIMM and MRC HIU, on Tuesday 1st March 2022.
Graham Ogg named NIHR Senior Investigator
3 March 2022
Seven academics in Oxford have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their outstanding leadership in research.
£1.2m Fellowship award for Robert Beagrie
3 March 2022
Congratulations to Dr Robert Beagrie on being awarded a Sir Henry Dale Fellowship from the Wellcome Trust.
Influenza virus toolkit announced
21 February 2022
The reagent repository will build research capacity for studying influenza viruses, and increase preparedness for the next influenza pandemic.